(Q38122420)

29 August 2017

title

MicroRNA-21: a therapeutic target for reversing drug resistance in cancer (English)

1 reference

29 August 2017

1 reference

Liu Hong

1

1 reference

29 August 2017

Yu Han

2

1 reference

29 August 2017

Yujie Zhang

3

1 reference

29 August 2017

Hongwei Zhang

4

1 reference

29 August 2017

Qingchuan Zhao

5

1 reference

29 August 2017

Kaichun Wu

6

1 reference

29 August 2017

Daiming Fan

7

1 reference

29 August 2017

language of work or name

English

0 references

publication date

19 July 2013

1 reference

Expert Opinion on Therapeutic Targets

29 August 2017

published in

1 reference

29 August 2017

volume

17

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

1073-1080

1 reference

Immunotherapy: a useful strategy to help combat multidrug resistance

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

miRNAs as mediators of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

The microcosmos of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21: a novel therapeutic target in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Intracellular and extracellular microRNAs in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

The roles of copper transporters in cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Drug resistance-related microRNAs in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNAs in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-regulated networks: the perfect storm for classical molecular biology, the ideal scenario for systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

miR-210: a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

OncomiRs: the discovery and progress of microRNAs in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

miR-21 as a key regulator of oncogenic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Clinical outcome prediction by microRNAs in human cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Targeting miR-21 in glioma: a small RNA with big potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21: from cancer to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Targeting CSC-related miRNAs for cancer therapy by natural agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

BMPRII is a direct target of miR-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

Growth inhibition by miR-519 via multiple p21-inducing pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.819853

10.1517/14728222.2013.819853

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference